innovative vaccine platform that helps prevent infections and reduce the global threat of antimicrobial resistance
Vaxdyn has raised €15M across 1 funding round from 1 investor, most recently a round in Sep 2024. Based in Seville, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-04 | Other | €15M |
| EIC Accelerator |
| View deal → |
